Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

XGN

Exagen (XGN)

Exagen Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:XGN
일자시간출처헤드라인심볼기업
2024/09/0507:12Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XGNExagen Inc
2024/09/0507:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
2024/09/0505:05GlobeNewswire Inc.Exagen Inc. to Participate in the 2024 Cantor Global Healthcare ConferenceNASDAQ:XGNExagen Inc
2024/08/1006:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XGNExagen Inc
2024/08/0522:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XGNExagen Inc
2024/08/0521:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
2024/08/0521:00GlobeNewswire Inc.Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record PerformanceNASDAQ:XGNExagen Inc
2024/08/0306:20Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:XGNExagen Inc
2024/08/0222:00GlobeNewswire Inc.Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:XGNExagen Inc
2024/08/0221:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
2024/08/0122:00GlobeNewswire Inc.Exagen Appoints Jeffrey G. Black as New Chief Financial OfficerNASDAQ:XGNExagen Inc
2024/07/2222:00GlobeNewswire Inc.Exagen to Announce Second Quarter 2024 Results on August 5, 2024NASDAQ:XGNExagen Inc
2024/06/1305:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
2024/06/1305:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
2024/06/1305:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
2024/06/1205:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
2024/05/1709:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
2024/05/1505:25AllPennyStocks.comHealthcare Shares Soar Following Major Price Target IncreaseNASDAQ:XGNExagen Inc
2024/05/1322:30Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XGNExagen Inc
2024/05/1322:27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XGNExagen Inc
2024/05/1321:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
2024/05/1321:00GlobeNewswire Inc.Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full YearNASDAQ:XGNExagen Inc
2024/05/0705:05GlobeNewswire Inc.Exagen Announces Campaign for Lupus Awareness MonthNASDAQ:XGNExagen Inc
2024/05/0105:05GlobeNewswire Inc.Exagen to Announce First Quarter 2024 Results on May 13, 2024NASDAQ:XGNExagen Inc
2024/04/2621:30GlobeNewswire Inc.Exagen Inc. Announces Changes to the Board of DirectorsNASDAQ:XGNExagen Inc
2024/03/1821:00GlobeNewswire Inc.Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 ResultsNASDAQ:XGNExagen Inc
2024/03/1820:12IH Market NewsAnticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See UpticksNASDAQ:XGNExagen Inc
2024/03/0823:00GlobeNewswire Inc.Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor ForumNASDAQ:XGNExagen Inc
2024/03/0806:05GlobeNewswire Inc.Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024NASDAQ:XGNExagen Inc
2024/03/0706:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
 검색 관련기사 보기:NASDAQ:XGN